Flavone Acetic Acid and Its Effects on Tumors in Mice
Author Information
Author(s): M.C. Bibby, R.M. Phillips, J.A. Double
Primary Institution: Clinical Oncology Unit, University of Bradford
Hypothesis
The study aims to examine the tissue disposition of flavone acetic acid (FAA) to explain its site-dependent anti-tumor activity.
Conclusion
The site-dependent activity of FAA cannot be fully explained by differences in drug bioavailability or pharmacokinetic profiles caused by large tumor loads.
Supporting Evidence
- FAA shows significant activity against subcutaneous tumors in mice.
- Previous studies indicated that lung tumor deposits are less responsive to FAA.
- FAA clearance curves are influenced by the presence of MAC 15A tumors.
- Decreased clearance of FAA does not explain the resistance of lung deposits.
- Cytotoxic metabolites have not been detected in vitro or in vivo.
Takeaway
This study looked at how a drug called flavone acetic acid works differently on tumors in mice depending on where the tumors are located.
Methodology
The study used NMRI mice with MAC 15A tumors, administering FAA and measuring its pharmacokinetics in plasma and tissues.
Limitations
The reasons for the site-dependent activity of FAA remain unclear.
Participant Demographics
Pure strain NMRI mice, aged 6-8 weeks.
Want to read the original?
Access the complete publication on the publisher's website